泰首富系內正大企業國際(03839.HK)曾飆56%創九個月高 據報馬雲與謝國民在港會晤
由泰國首富謝國民長子謝吉人任董事長的正大企業國際(03839.HK)今日(30日)高開6.3%,報0.84元後,早段升幅急擴,曾升55.7%,最高見1.23元創約九個月高。現報1.13元,升43.04%,成交124.76萬股,涉資128.01萬元。
據《經濟日報》報道,阿裏-SW(09988.HK)創辦人馬雲在港過農曆新年,更與泰國首富兼正大集團資深董事長謝國民及其三兒子,以及正大行政總裁謝熔仁會面。
繼上月馬雲曾到訪曼谷考察正大集團後,今次是馬雲與謝國民在不足一個月內第二次見面。據悉,馬雲本月在香港頻頻與內地、香港以及東南亞財金界人士會面,而今次謝國民飛往香港,外界猜測可能會與馬雲進行投資合作。
另由謝國民侄孫女謝其潤任主席的藍籌中生製藥(01177.HK)現報4.81元,跌2.04%,成交1,913.3萬股,涉資9,284.8萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.